Engineering Defensin α-helix to produce high-affinity SARS-CoV-2 Spike protein binding ligands.
L. A. Fernandes, A. A. Gomes, M. d. L. B. Magalhaes, P. Ray, G. F. da Silva
This paper engineers defensin α-helices to create high-affinity SARS-CoV-2 Spike protein binding ligands for diagnostics and therapy.
bioRxiv · Feb 9, 2022Bioengineering